Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
6
×
national blog main
new york blog main
6
×
biotech
boston blog main
new york top stories
boston top stories
national top stories
startups
boston
clinical trials
deals
merck
regeneron pharmaceuticals
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
vc
wisconsin blog main
wisconsin top stories
abeona therapeutics
affordable care act
agios pharmaceuticals
alirocuma
alirocumab
alnylam pharmaceuticals
alzheimer's
ameet nathwani
amgen
aphelion capital
arches
azacitidine
beta-thalassemia
biolinq
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
codiak biosciences
What
based
6
×
new
medicines
million
research
startup
add
adds
advance
aims
alnylam
american
approach
begin
best
bio
biolinq
biosciences
biosensor
biotech
bio’s
brings
bubbles
called
cells
cholesterol
class
clinical
codiak
company
continue
crash
data
deal
debate
debuts
deerfield
developing
diabetes
domestic
Language
unset
Current search:
xconomy.com
×
based
×
" life sciences "
×
" new york blog main "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Shine Raises $30M, Could Add $150M More After Inking Deerfield Deal